Skip to main content
logo
Tanvex BioPharma, Inc. (TPE:6541)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.60
-1.20 (-3.17%)
Jul 30, 2026, 1:30 PM CST

Tanvex BioPharma Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
483.94400.9734.6861.4122.45.41
Revenue Growth
496.11%1056.27%-43.53%174.11%314.43%1702.00%
Gross Profit
-685.21-440.718.2959.7-19.353.55
Operating Income
-1,380-1,388-1,357-2,101-1,606-1,599
Net Income
-1,423-1,500-1,382-2,137-1,641-1,543
Earnings Per Share
-5.58-6.13-8.90-16.58-13.95-14.21
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan
170.03-53.722.45.41
United States
230.9434.687.71--
Total
400.9734.6861.4122.45.41

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
442.24878.71376.96380.75786.232,223
Total Debt
1,6761,5781,6481,7321,8391,759
Net Cash (Debt)
-1,234-699.69-1,271-1,351-1,053463.95
Net Cash Growth
------15.52%
Net Cash Per Share
-4.83-2.86-8.19-10.48-8.954.27

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,026-1,005-1,151-1,435-1,334-1,387
Capital Expenditures
-835.37-668.26-105.91-71.02-93.5-29.82
Free Cash Flow
-1,861-1,674-1,257-1,506-1,427-1,417
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-141.59%-109.91%23.91%97.21%-86.36%65.67%
Operating Margin
-285.13%-346.21%-3912.40%-3420.80%-7166.21%-29581.65%
Pretax Margin
-294.07%-374.89%-3982.94%-3479.30%-7325.06%-28545.86%
Profit Margin
-294.07%-374.13%-3983.94%-3480.00%-7325.16%-28546.26%
FCF Margin
-384.63%-417.41%-3623.36%-2452.94%-6370.97%-26208.75%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
20.7036.32308.48141.91552.433787.62